The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metabolism-based GP-2250 in combination with gemcitabine as a novel approach to pancreatic cancer: a mouse xenograft study.
 
Chris Braumann
No Relationships to Disclose
 
Marie Buchholz
No Relationships to Disclose
 
Britta Majchrzak - Stiller
No Relationships to Disclose
 
Stephan Hahn
No Relationships to Disclose
 
Waldemar Uhl
Research Funding - KCI; Pfizer; Takeda
 
Anup Kasi
Honoraria - OncLive
Research Funding - Astellas Pharma (Inst); Geistlich Pharma (Inst); Halozyme (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
Travel, Accommodations, Expenses - Halozyme; Rafael Pharmaceuticals
 
Dr. Thomas Mueller
Employment - Geistlich Pharma